Introducing the new leadership team at ImpediMed, driven by a shared vision for success. Parmjot Bains , MBChB, M Phil, our CEO and Managing Director, states, 'Our focus is on preventing the painful condition affecting many cancer sufferers and generating future value for shareholders.' Explore how our fresh direction is reshaping the future of healthcare. Dive into the article now: 🔗https://ow.ly/CSFb50RhJJF
ImpediMed’s Post
More Relevant Posts
-
📢 Exciting insights from our brainstorming lung session at #MEDSIR last Monday 🧠💡 Check out the article to dive into the collaborative ideas and innovative strategies we explored. #Collaboration #Innovation 🚀🔗
On January 29th, MEDSIR hosted its inaugural Brainstorming Session for 2024, centering around thoracic malignancies. The Brainstorming Series offers oncologists the chance to participate in discussions, staying attuned to emerging needs and exploring possibilities for Investigator-Initiated Trials (IITs). Discover more: https://lnkd.in/dRDFhUrh Carles Escriu, Giulia Raimondi, PhD, Giuseppe Banna, Alfredo Addeo, Juan Felipe Slebe Concha, Federica Turrisi, Antonio Calles #MEDSIRBrainstormingSeries #LungCancer #ClinicalTrials #Innovation
MEDSIR's Brainstorming Series: Advancing Innovations in Thoracic Malignancies
medsir.org
-
Board Certified Genetic Counselor with 7+ years of clinical genetic counseling experience and 15+ years of additional experience in the pharmaceutical industry in genomics-driven cancer research and devlopment.
Another great MCGI Forum! And if you have a patient with a KRAS mutation, please tell them about the #KRASholes.
Did you miss day 1 of the MCGI Forum? Don't be a #KRAShole! Join us at 8:30 AM tomorrow. We had an amazing first day filled with engaging discussions, reconnecting with colleagues, and working together to kick cancers #KRAS! A big thank you to Terri Conneran and Barbara Segarra-Vazquez for being part of this year's event.
-
-
Greentree Quarterly Newsletter: Continuing Our Journey Towards Sustainability! 🌱 We are excited to present the second edition of Greentree’s Quarterly Newsletter! As we move forward on our path towards innovation and environmental responsibility, we remain dedicated to keeping you updated on our initiatives, insights, and the positive impact we’re making. In this edition, you'll discover: - An exclusive interview with Oscar from our technical team, sharing his insights and dedication to our mission - An introduction to our Breast Cancer Awareness initiative - Celebrating our achievements with a showcase of awards we've collected over the years - Expert tips on maximising cartridge life and improving print quality for your toner products - An updated price list and catalogue, featuring our latest offerings and bundles At Greentree, we believe in the power of collaboration and transparency. We strive to build a community that shares our commitment to creating a greener and healthier planet. Join us as we continue this journey towards a more sustainable future. Thank you for being an essential part of our story. Together, we can make a difference! Stay tuned, stay green! 🌍💚 #Greentree #Sustainability #CommunitySupport #TechnicalExcellence #QuarterlyNewsletter
-
Dive deep into AdAlta featuring Andrew Musgrave and Tim Oldham, CEO & Managing Director AdAlta. Tim discusses AdAlta's revolutionizing treatments with our unique i-body platform. Our lead product, AD-214, is showing promise in treating fibrotic diseases. Here's what you'll learn: · AdAlta's mission and focus areas · The groundbreaking i-body technology and its advantages · Exciting updates on the Phase I clinical trials and partnering for AD-214 · Strategic partnerships boosting R&D efforts · The establishment of cellular immunotherapy initiative AdCella and its impact · AdAlta's vision for the future Tune in here: https://lnkd.in/gDabUQVa
-
-
“Nothing would have changed if I hadn’t gone from just fighting to survive to fighting for a solution for my disease,” says David Fajgenbaum, co-founder Every Cure. In this video, he talks about his journey from facing a medical emergency situation to find solutions through horizontal thinking. ➡ Do you leverage out-of-the-box thinking? Share your thoughts in the comments.
Do you think outside the box? Or within it? David Fajgenbaum, MD, MBA, MSc promised his mother he’d become an oncologist before she passed away of cancer. But in his third year of medical school, Fajgenbaum, a former college quarterback and current co-founder of Every Cure, nearly died when all his vital organs mysteriously shut down. After an experimental drug failed and doctors had run out of options, Fajgenbaum employed the transformative power of horizontal thinking. Unlike vertical thinking, which is a sequence of direct and logical steps used to come to a conclusion, horizontal thinking takes a solution from one problem and applies it to another in a way that sparks innovation and adaptability. “Nothing would have changed if I hadn’t gone from just fighting to survive to fighting for a solution for my disease,” Fajgenbaum said. So, which are you: a vertical thinker or a horizontal thinker? Share your thoughts in the comments! Tune into this episode of Catalyst to see how Fajgenbaum used horizontal thinking to save his own life, as well as those of countless others. And subscribe to the newsletter: https://lnkd.in/e-RYcKD5
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
-
We launched the Health Equity Innovation Fund in 2019 to support organizations with transformative ideas to advance the healthcare system and eliminate deep-rooted inequities. Since then, 77% of Innovation Fund grantees have reported increased commitment to health equity work at their institutions. Swipe to see how grantees Touch, The Black Breast Cancer Alliance, Equify Health, and Henry Ford Health have used their funding to shift power to patients and unlock innovation in care delivery, and learn more about the impact of the Innovation Fund here: https://lnkd.in/dT_tvBZ4
-
Transforming Healthcare with Innovative Tech Solutions | Empowering Oncology Practices for Better Outcomes
🚀 Exciting news! Next week, I’ll be attending the 2024 Association for Value-Based Cancer Care Conference in New York, and couldn’t be more thrilled to share the stage with some of the brightest minds in oncology and technology. 💡🎤 We’ll be diving deep into "The Practice Analytics Imperative: Better Measurement for Better Management." 🔍 In today’s data-driven world, oncology practices are sitting on vast amounts of information, but unlocking the real value requires breaking down silos and improving interoperability. I'll be sharing my thoughts on: - The most persistent barriers to interoperability 🧩 - How AI and technology are shaping the future of practice analytics ⚙️ - Solutions to help practices leverage their data, even when they lack in-house expertise 💼 It’s going to be an insightful discussion, and I can’t wait to hear perspectives from industry leaders and share Navista's vision on how we can help practices harness the full potential of their data. If you’re attending, let’s connect! Looking forward to learning, sharing, and driving innovation in the oncology space. #AVBCC2024 #OncologyAnalytics #ValueBasedCare #Interoperability #HealthcareInnovation #DataDrivenDecisions #Navista #OncologyLeadership
Navista is excited to take the stage at the 2024 Association for Value-Based Cancer Care conference later this month! Headed to New York for #AVBCC24? Make plans to check out the following sessions featuring Navista leaders: Nini Wu, MD, Chief Medical & Development Officer: "Artificial Intelligence and the Future Ahead for Providers" - 10/16, 11 a.m. ET Mike Fazio, Head of Value-Based Care: "Value-Based Care: Is it Evolution or a Revolution" - 10/16, 8 a.m. ET "Can We Transform Healthcare From Within?" - 10/18, 9 a.m. ET Anish Arora, VP, Product Management: "The Practice Analytics Imperative: Better Measurement for Better Management" - 10/16, 9 a.m. ET For more on Navista, visit: https://lnkd.in/gZMB95iZ. #AVBCC2024 #ValueBasedCancerCare #ValueBasedCare #communityoncology
-
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
